AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding AC Immune SA changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 42 | 40 | −2 |
| Shares | 24.5M | 24.6M | +121.7K (+0.5%) |
| Value | $49.7M | $71.1M | +$21.4M (+43.1%) |
New holders (4)
Institutions that held AC Immune SA at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 189,892 | $548.8K | 0.00% |
| Susquehanna International Group, LLP | 21,840 | $63.1K | 0.00% |
| Private Advisor Group, LLC | 16,600 | $48.0K | 0.00% |
| Rockefeller Capital Management L.P. | 1,000 | $2.89K | 0.00% |
Sold out (6)
Institutions that held AC Immune SA at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Marshall Wace, LLP | 135,841 | $275.8K |
| Handelsbanken Fonder AB | 105,000 | $213.0K |
| Eversept Partners, LP | 100,752 | $204.5K |
| Cantor Fitzgerald, L. P. | 30,000 | $60.9K |
| Squarepoint Ops LLC | 12,642 | $25.7K |
| Two Sigma Securities, LLC | 10,085 | $20.5K |